Cardioprotective effects of poly(ADP-ribose) polymerase inhibition

Keyphrases

• Myocytes 100%
• Poly (ADP-ribose) Polymerase Inhibition 100%
• Cardioprotection 100%
• Poly(ADP-ribose) Polymerase 66%
• Ischemia-reperfusion Injury 66%
• Aging 33%
• Cardiomyopathy 33%
• Cell Culture 33%
• Beneficial Effects 33%
• Rodent Models 33%
• DNA Double-strand Breaks 33%
• Free Radicals 33%
• Drug Exposure 33%
• Heart Failure 33%
• Metabolic Cycle 33%
• Nicotinamide Adenine Dinucleotide (NAD+) 33%
• Preclinical Large Animal Model 33%
• Global Ischemia 33%
• Local Ischemia 33%
• Functional Impairment 33%
• Cardiotoxicity 33%
• Myocyte Damage 33%

Medicine and Dentistry

• Poly ADP Ribose Polymerase 100%
• Cardiac Muscle Cell 50%
• Muscle Cell 50%
• Injury 25%
• In Vitro 25%
• Cell Culture 25%
• Oxidizing Agent 25%
• DNA Strand Breakage 25%
• Free Radical 25%
• Ischemia 25%
• Adenosine Diphosphate 25%
• Functional Disease 25%
• Reperfusion Injury 25%
• Congestive Heart Failure 25%
• Drug Exposure 25%
• Myocardial Disease 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 100%
• Injury 25%
• Cell Culture 25%
• Ischemia 25%
• Free Radical 25%
• Congestive Heart Failure 25%
• Oxidizing Agent 25%
• Reperfusion Injury 25%
• Adenosine Diphosphate 25%
• Functional Disease 25%
• Myocardial Disease 25%